First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

Citation

Khot, A, Brajanovski, N, Cameron, D et al 2019, 'First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study', Cancer Discovery, vol. 9, no. 8, pp. 1036-1049.

Year

2019

Fields of Research

  • Haematology
  • Cancer Cell Biology
  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)

Updated:  01 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers